Siwei Li

989 total citations
25 papers, 556 citations indexed

About

Siwei Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Siwei Li has authored 25 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Siwei Li's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Siwei Li is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (3 papers). Siwei Li collaborates with scholars based in China, United States and Canada. Siwei Li's co-authors include Patrick A. Limbach, Yi Sang, Guofu Huang, Jun Yang, Xinmei Chen, Yi Wang, Qian Wang, Zhixiang Wang, Duxin Sun and Lijuan Liu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Oncogene.

In The Last Decade

Siwei Li

24 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siwei Li China 13 403 129 90 40 38 25 556
Thibauld Oullier France 12 510 1.3× 109 0.8× 145 1.6× 62 1.6× 110 2.9× 27 819
Haidar Akl Belgium 9 447 1.1× 41 0.3× 79 0.9× 47 1.2× 39 1.0× 17 593
André L. S. Cruz Brazil 6 389 1.0× 222 1.7× 55 0.6× 63 1.6× 12 0.3× 6 622
Srikant Viswanadha United States 18 348 0.9× 41 0.3× 137 1.5× 131 3.3× 68 1.8× 65 795
Xiaohong Song China 12 364 0.9× 63 0.5× 107 1.2× 44 1.1× 8 0.2× 22 594
Ann-Jeng Liu Taiwan 14 302 0.7× 209 1.6× 35 0.4× 37 0.9× 9 0.2× 15 463
Bo Mu China 13 316 0.8× 158 1.2× 180 2.0× 99 2.5× 7 0.2× 26 562
Haifeng Yang China 13 220 0.5× 90 0.7× 63 0.7× 35 0.9× 11 0.3× 27 391
Zhongqiang Guo China 13 346 0.9× 150 1.2× 90 1.0× 35 0.9× 26 0.7× 24 539
Yasuko Tamura United States 9 198 0.5× 95 0.7× 145 1.6× 45 1.1× 52 1.4× 10 486

Countries citing papers authored by Siwei Li

Since Specialization
Citations

This map shows the geographic impact of Siwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwei Li more than expected).

Fields of papers citing papers by Siwei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwei Li. The network helps show where Siwei Li may publish in the future.

Co-authorship network of co-authors of Siwei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Siwei Li. A scholar is included among the top collaborators of Siwei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siwei Li. Siwei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Siwei, et al.. (2025). Development of DeepPQK and DeepQK sequence-based deep learning models to predict protein-ligand affinity and application in the directed evolution of ferulic esterase DLfae4. International Journal of Biological Macromolecules. 307(Pt 1). 141790–141790. 1 indexed citations
2.
Li, Siwei, Shuibin Wang, Lu Zhang, et al.. (2024). METTL3 methylated KIF15 promotes nasopharyngeal carcinoma progression and radiation resistance by blocking ATG7-mediated autophagy through the activation of STAT3 pathway. Translational Oncology. 51. 102161–102161. 1 indexed citations
3.
Liu, Lang, Youjun Zeng, Lin Ma, et al.. (2023). Intensity Interrogation-Based High-Sensitivity Surface Plasmon Resonance Imaging Biosensor for Apoptosis Detection in Cancer. Biosensors. 13(10). 946–946. 6 indexed citations
4.
Liu, Zhongjun, et al.. (2022). Hsa_ Circ_0005044 Promotes Osteo/Odontogenic Differentiation of Dental Pulp Stem Cell Via Modulating miR-296-3p/FOSL1. DNA and Cell Biology. 42(1). 14–26. 7 indexed citations
5.
Li, Siwei, Guoliang Pi, Yong Zeng, et al.. (2022). Notoginsenoside R1 induces oxidative stress and modulates LPS induced immune microenvironment of nasopharyngeal carcinoma. International Immunopharmacology. 113(Pt A). 109323–109323. 9 indexed citations
6.
7.
Cheng, Chun, Siwei Li, Jun Yang, et al.. (2021). CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing β-catenin. Oncogene. 40(16). 2842–2857. 33 indexed citations
8.
Cheng, Chun, Jun Yang, Siwei Li, et al.. (2021). HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target. Cell Death and Disease. 12(2). 137–137. 39 indexed citations
9.
Li, Siwei, Danying Lin, Xiaohui Zou, et al.. (2021). Mutifocal image scanning microscopy based on double-helix point spread function engineering. Acta Physica Sinica. 70(3). 38701–38701.
10.
Huddle, Brandt C., Edward Grimley, Cameron D. Buchman, et al.. (2020). Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy. European Journal of Medicinal Chemistry. 211. 113060–113060. 13 indexed citations
11.
12.
Sang, Yi, et al.. (2019). Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis. International Journal of Oncology. 54(3). 1112–1122. 18 indexed citations
13.
Li, Siwei, et al.. (2018). Determining the mechanisms behind distribution variability in small molecule pharmaceuticals using 3D spheroid tissues. Drug Metabolism and Pharmacokinetics. 33(1). S67–S67. 1 indexed citations
14.
Zhao, Yujun, Bing Zhou, Longchuan Bai, et al.. (2018). Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. Journal of Medicinal Chemistry. 61(14). 6110–6120. 33 indexed citations
15.
Zhao, Yujun, Longchuan Bai, Liu Liu, et al.. (2017). Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. Journal of Medicinal Chemistry. 60(9). 3887–3901. 35 indexed citations
16.
Patel, Twisha S, Sandro Cinti, Duxin Sun, et al.. (2016). Oseltamivir for pandemic influenza preparation: Maximizing the use of an existing stockpile. American Journal of Infection Control. 45(3). 303–305. 8 indexed citations
17.
Wetzel, Collin, Siwei Li, & Patrick A. Limbach. (2014). Metabolic De-Isotoping for Improved LC-MS Characterization of Modified RNAs. Journal of the American Society for Mass Spectrometry. 25(7). 1114–1123. 11 indexed citations
18.
Li, Siwei & Patrick A. Limbach. (2013). Mass spectrometry sequencing of transfer ribonucleic acids by the comparative analysis of RNA digests (CARD) approach. The Analyst. 138(5). 1386–1386. 21 indexed citations
19.
Yang, Xue, Siwei Li, Zhijie Lin, et al.. (2013). The Inhibitory Helix Controls the Intramolecular Conformational Switching of the C-Terminus of STIM1. PLoS ONE. 8(9). e74735–e74735. 38 indexed citations
20.
Li, Siwei & Patrick A. Limbach. (2012). Method for Comparative Analysis of Ribonucleic Acids Using Isotope Labeling and Mass Spectrometry. Analytical Chemistry. 84(20). 8607–8613. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thibauld Oullier Breakdown of academic impact, for papers by Haidar Akl Breakdown of academic impact, for papers by André L. S. Cruz Breakdown of academic impact, for papers by Srikant Viswanadha Breakdown of academic impact, for papers by Xiaohong Song Breakdown of academic impact, for papers by Ann-Jeng Liu Breakdown of academic impact, for papers by Bo Mu Breakdown of academic impact, for papers by Haifeng Yang Breakdown of academic impact, for papers by Zhongqiang Guo Breakdown of academic impact, for papers by Yasuko Tamura
Rankless by CCL
2026